Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sr9009
1. Sr9009
2. 1379686-30-2
3. Sr-9009
4. Sr 9009
5. Stenabolic (sr9009)
6. X5dca09n30
7. Chembl1961796
8. 1-pyrrolidinecarboxylic Acid, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-, Ethyl Ester
9. Stenabolic
10. 1-pyrrolidinecarboxylic Acid, 3-[[[(4-chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-, Ethyl Ester
11. Rev-erb Agonist Ii
12. Unii-x5dca09n30
13. Gtpl8901
14. Ex-a726
15. Sr 9009 [who-dd]
16. Dtxsid901045515
17. Bcp16215
18. Bdbm50366238
19. Mfcd29472236
20. Nsc810521
21. S8692
22. Akos027470307
23. Ccg-269102
24. Cs-4669
25. Db14013
26. Nsc-810521
27. Sb19006
28. Ncgc00384202-01
29. Ac-30219
30. As-55859
31. Hy-16989
32. A886340
33. J-690150
34. Q15410184
35. Ethyl 3-(4-chlorobenzyl)((5-nitrothiophen-2-yl)methylaminomethyl)pyrrolidine-1-carboxylate
36. N'-[(1e)-1-(5-chloro-2-hydroxyphenyl)ethylidene]-3-(4-morpholinylsulfonyl)benzohydrazide
37. Ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitro-2-thienyl)methyl]amino]methyl]pyrrolidine-1-carboxylate
38. Ethyl 3-[[[(4-chlorophenyl)methyl][(5-nitro-2-thienyl)methyl]amino]methyl]-1-pyrrolidinecarboxylate
Molecular Weight | 437.9 g/mol |
---|---|
Molecular Formula | C20H24ClN3O4S |
XLogP3 | 4.4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 8 |
Exact Mass | 437.1176051 g/mol |
Monoisotopic Mass | 437.1176051 g/mol |
Topological Polar Surface Area | 107 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 556 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A SR9009 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of SR9009, including repackagers and relabelers. The FDA regulates SR9009 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. SR9009 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of SR9009 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A SR9009 supplier is an individual or a company that provides SR9009 active pharmaceutical ingredient (API) or SR9009 finished formulations upon request. The SR9009 suppliers may include SR9009 API manufacturers, exporters, distributors and traders.
click here to find a list of SR9009 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
SR9009 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of SR9009 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right SR9009 GMP manufacturer or SR9009 GMP API supplier for your needs.
A SR9009 CoA (Certificate of Analysis) is a formal document that attests to SR9009's compliance with SR9009 specifications and serves as a tool for batch-level quality control.
SR9009 CoA mostly includes findings from lab analyses of a specific batch. For each SR9009 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
SR9009 may be tested according to a variety of international standards, such as European Pharmacopoeia (SR9009 EP), SR9009 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (SR9009 USP).
LOOKING FOR A SUPPLIER?